Nanomaterials in Drug Delivery: Strengths and Opportunities in Medicine

Chinedu O. Egwu,Chinyere Aloke,Kenneth T. Onwe,Chukwunalu Igbudu Umoke,Joseph Nwafor,Robert A. Eyo,Jennifer Adaeze Chukwu,Godswill O. Ufebe,Jennifer Ladokun,David Tersoo Audu,Anthony O. Agwu,David Chukwu Obasi,Chukwuemeka O. Okoro
DOI: https://doi.org/10.3390/molecules29112584
IF: 4.6
2024-06-01
Molecules
Abstract:There is a myriad of diseases that plague the world ranging from infectious, cancer and other chronic diseases with varying interventions. However, the dynamism of causative agents of infectious diseases and incessant mutations accompanying other forms of chronic diseases like cancer, have worsened the treatment outcomes. These factors often lead to treatment failure via different drug resistance mechanisms. More so, the cost of developing newer drugs is huge. This underscores the need for a paradigm shift in the drug delivery approach in order to achieve desired treatment outcomes. There is intensified research in nanomedicine, which has shown promises in improving the therapeutic outcome of drugs at preclinical stages with increased efficacy and reduced toxicity. Regardless of the huge benefits of nanotechnology in drug delivery, challenges such as regulatory approval, scalability, cost implication and potential toxicity must be addressed via streamlining of regulatory hurdles and increased research funding. In conclusion, the idea of nanotechnology in drug delivery holds immense promise for optimizing therapeutic outcomes. This work presents opportunities to revolutionize treatment strategies, providing expert opinions on translating the huge amount of research in nanomedicine into clinical benefits for patients with resistant infections and cancer.
chemistry, multidisciplinary,biochemistry & molecular biology
What problem does this paper attempt to address?
This paper aims to explore the advantages and opportunities of nanomaterials in drug delivery, especially their applications in the medical field. Specifically, the paper attempts to address the following key issues: 1. **Limitations of traditional drug delivery systems**: Traditional drug delivery methods (such as oral administration, intravenous injection, etc.) pose many challenges, including drug efflux from the target, drug degradation, drug toxicity, etc. These factors often lead to treatment failure. The paper explores how to improve drug delivery through nanotechnology to overcome these limitations. 2. **Potential of nanotechnology in drug delivery**: Nanotechnology improves the safety and efficacy of drugs by enhancing drug stability, water solubility, prolonging drug circulation time, increasing the uptake rate of target cells or tissues, and reducing enzyme degradation. The paper discusses in detail the various applications of nanoparticles (NPs) in drug delivery, including targeted delivery, controlled release, improving drug stability, and improving pharmacokinetic properties. 3. **Advantages of nano - drug delivery systems**: - **Targeted delivery**: By encapsulating drugs in nanoparticles, these particles can be designed to accumulate in specific tissues or cells, thereby increasing the drug concentration in the target area, reducing the impact on healthy tissues, reducing toxicity, and improving efficacy. - **Controlled release**: Nanotechnology can achieve precise and gradual release of drugs, ensuring a continuous and stable supply of drugs at the target site, optimizing the treatment effect and improving patient compliance. - **Improving drug stability**: Nanoparticles can protect drugs from environmental factors and improve their stability during storage and use. - **Improving pharmacokinetic properties**: By binding to nanoparticles, drugs can be better absorbed, distributed to the target site, metabolized, and excreted, thereby increasing bioavailability and treatment effect. 4. **Challenges and solutions**: Although nanotechnology shows great potential in drug delivery, it still faces some challenges, such as regulatory approval, large - scale production, cost issues, and potential toxicity. The paper proposes methods to solve these problems by simplifying the regulatory process and increasing research funds. In summary, the main purpose of this paper is to explore the advantages and opportunities of nanotechnology in drug delivery and propose strategies to solve current challenges, in order to bring better treatment effects to patients in clinical practice.